跳至主要内容
临床试验/NL-OMON32352
NL-OMON32352招募中不适用

DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of ADVERSE DRUG REACTIONS: An international multicenter study. - ADR risk score

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients aged 65 and over, admitted to the participating Departments during the study period will be enrolled and followed until discharge or death.

排除标准

  • 1.Age < 65 years old
  • 2.Unwillingness to sign the written informed consent form
  • 3.Oncology patients on anti-cancer drugs or on any other active treatment for their cancer, except those on tamoxifen
  • 4.Patients transferred from other departments or from the Intensive Care Unit.

研究者

相似试验